Pharos iBio Co., Ltd. (KOSDAQ:388870)
5,960.00
+40.00 (0.68%)
At close: Oct 23, 2026
| Market Cap | 77.16B +10.2% |
| Revenue (ttm) | n/a |
| Net Income | -9.49B |
| EPS | -733.04 |
| Shares Out | 12.95M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 25,444 |
| Open | 5,790.00 |
| Previous Close | 5,920.00 |
| Day's Range | 5,790.00 - 6,040.00 |
| 52-Week Range | 3,710.00 - 12,120.00 |
| Beta | -0.36 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 11, 2026 |